A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence

[1]  E. Caron,et al.  Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity , 2022, Cancer discovery.

[2]  I. Ben-Porath,et al.  Senescent stromal cells: roles in the tumor microenvironment. , 2022, Trends in cancer.

[3]  A. Donato,et al.  Mechanisms and consequences of endothelial cell senescence , 2022, Nature Reviews Cardiology.

[4]  S. Lowe,et al.  Senescence rewires microenvironment sensing to facilitate anti-tumor immunity , 2022, bioRxiv.

[5]  Lieping Chen,et al.  Resistance Mechanisms to Anti-PD Cancer Immunotherapy. , 2022, Annual review of immunology.

[6]  R. Bernards,et al.  Exploiting senescence for the treatment of cancer , 2022, Nature Reviews Cancer.

[7]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[8]  N. LeBrasseur,et al.  A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues , 2021, Nature Communications.

[9]  Hong Wu,et al.  ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma , 2021, Frontiers in Oncology.

[10]  A. Puisieux,et al.  Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis , 2021, Cancers.

[11]  N. Chandel,et al.  Cancer metabolism: looking forward , 2021, Nature Reviews Cancer.

[12]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[13]  A. Griffioen,et al.  Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes , 2021, Nature Reviews Clinical Oncology.

[14]  J. Gil,et al.  Similarities and interplay between senescent cells and macrophages , 2020, The Journal of cell biology.

[15]  Sung Young Kim,et al.  Endothelial cell senescence: A machine learning-based meta-analysis of transcriptomic studies , 2020, Ageing Research Reviews.

[16]  Lihua Zhang,et al.  Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.

[17]  M. Zhang,et al.  Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer , 2020, Briefings in bioinformatics.

[18]  T. Kirkwood,et al.  On the evolution of cellular senescence , 2020, Aging cell.

[19]  Fei Liu,et al.  Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence , 2020, Breast cancer research : BCR.

[20]  Justine Jia Wen Seow,et al.  Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma , 2020, Cell.

[21]  P. Singh,et al.  How does fascin promote cancer metastasis? , 2020, The FEBS journal.

[22]  Jae-Seon Lee,et al.  Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells. , 2020, Cancer letters.

[23]  M. Demaria,et al.  Senescent Cells in Cancer Therapy: Friends or Foes? , 2020, Trends in cancer.

[24]  M. Bar‐eli,et al.  MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma , 2020, Oncoimmunology.

[25]  G. Rabinovich,et al.  Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression , 2019, The Journal of experimental medicine.

[26]  C. Schmitt,et al.  Cellular Senescence: Defining a Path Forward , 2019, Cell.

[27]  Kotb Abdelmohsen,et al.  Transcriptome signature of cellular senescence. , 2019, Nucleic acids research.

[28]  S. Stewart,et al.  Unmasking senescence: context-dependent effects of SASP in cancer , 2019, Nature Reviews Cancer.

[29]  E. Yeo.  Hypoxia and aging , 2019, Experimental & Molecular Medicine.

[30]  G. Linette,et al.  A Single Dose of Neoadjuvant PD-1 Blockade Predicts Clinical Outcomes in Resectable Melanoma , 2019, Nature Medicine.

[31]  Soyoung Lee,et al.  The dynamic nature of senescence in cancer , 2019, Nature Cell Biology.

[32]  T A Chan,et al.  Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  X. Liu,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[34]  Di Chen,et al.  Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer , 2018, Cell Death & Disease.

[35]  George Rajna.  Link Between Cancer and Aging , 2018 .

[36]  S. Schwartz,et al.  TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion , 2017, Aging.

[37]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[38]  E. Hara,et al.  Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2 , 2017, Nature Communications.

[39]  Shenghui He,et al.  Senescence in Health and Disease , 2017, Cell.

[40]  D. Sprinzak,et al.  Endothelial Notch1 Activity Facilitates Metastasis. , 2017, Cancer cell.

[41]  B. Kennedy,et al.  Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. , 2017, Cancer discovery.

[42]  J. Lunceford,et al.  IFN- γ –related mRNA profile predicts clinical response to PD-1 blockade , 2017 .

[43]  Jingqin Luo,et al.  Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis , 2016, Nature Communications.

[44]  M. Goligorsky,et al.  Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. , 2016, Kidney international.

[45]  M. Doroudian,et al.  Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities , 2016, Medicinal research reviews.

[46]  A. Pezeshki,et al.  Naturally occurring p16Ink4a-positive cells shorten healthy lifespan , 2016, Nature.

[47]  A. Snyder,et al.  Acquired resistance to immunotherapy and future challenges , 2016, Nature Reviews Cancer.

[48]  S. Chien,et al.  Activation of integrin α5 mediated by flow requires its translocation to membrane lipid rafts in vascular endothelial cells , 2016, Proceedings of the National Academy of Sciences.

[49]  K. Yaddanapudi,et al.  MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation , 2015, Cancer Immunology Research.

[50]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[51]  N. Hacohen,et al.  Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.

[52]  Yanping Zhang,et al.  TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence , 2014, EMBO molecular medicine.

[53]  G. Coukos,et al.  Tumor Endothelium FasL Establishes a Selective Immune Barrier Promoting Tolerance in Tumors , 2014, Nature Medicine.

[54]  K. Alitalo,et al.  A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. , 2013, Cancer cell.

[55]  J. Eaton,et al.  Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor , 2013, The Journal of Immunology.

[56]  J. Post,et al.  Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability , 2012, Vascular cell.

[57]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[58]  T. Whiteside,et al.  Tumor‐derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation , 2011, International journal of cancer.

[59]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[60]  Feng Tian,et al.  Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation. , 2010, Cancer letters.

[61]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[62]  A. L. Fridman,et al.  Critical pathways in cellular senescence and immortalization revealed by gene expression profiling , 2008, Oncogene.

[63]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[64]  G. Freeman,et al.  Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis , 2003, European journal of immunology.

[65]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[66]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[67]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[68]  R. Effros.  Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. , 1998, American journal of human genetics.